Cognitive Enhancers: 22nd Neuropharmacology Conference

Official Satellite to the 2012 Meeting of the Society for Neuroscience

Cognitive enhancement has become a subject of considerable research and, both in neuroscience and society at large, growing controversy. This satellite meeting will survey progress in the field from attempts to facilitate the substrates of memory and cognition in animal models to clinical studies targeted at major psychiatric disorders. Attendees will accordingly have a first-hand opportunity to learn about the broad spectrum of enhancement research ranging from epigenetics through synaptic plasticity and brain networks to behavior. Individual sessions include both cutting edge work on currently marketed drugs and experiments using novel, mechanism-based compounds. The program will therefore be of interest to those interested in present and future therapeutic prospects for autism, age-related cognitive decline, addiction, and depression. It also directly addresses the possibility of enhancement in normal subjects, a contentious issue that affects much of the neuroscience community.

Topics List

Enhancing brain substrates of cognition:
Plasticity and memory
Cortical systems
Enhancement as a treatment for cognitive disorders:
Aging
Spine dysfunction
Experience and epigenetics
Affective disorders
Schizophrenia
Autism spectrum disorders

For queries, please contact:

Richard Hart
Email: r.hart@elsevier.com